BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12595831)

  • 1. A bridge for the 21st century in heart transplantation?
    Felker GM; O'connor CM
    Am Heart J; 2003 Feb; 145(2):198-9. PubMed ID: 12595831
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M; De Luca L; Massie MB; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
    Aranda JM; Woo G; Pauly DF; Rodriguez E; Hill JA; Schofield RS
    J Heart Lung Transplant; 2004 Feb; 23(2):260-1. PubMed ID: 14761776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 7. Is monitoring milrinone therapy useful in advanced heart failure?
    Vazir A; Leaver N; Lyster H; Alexanian A; Wilton P; Banner NR
    Int J Cardiol; 2011 Jun; 149(3):380-1. PubMed ID: 21450357
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current views on Milrinon--a PDE-III-inhibitor].
    Anaesthesist; 1994 Mar; 43(3 Suppl):1-16. PubMed ID: 9209531
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
    Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.
    Szarpak L; Szwed P; Gasecka A; Rafique Z; Pruc M; Filipiak KJ; Jaguszewski MJ
    ESC Heart Fail; 2022 Jun; 9(3):2049-2050. PubMed ID: 35384369
    [No Abstract]   [Full Text] [Related]  

  • 12. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
    Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone, a bridge to heart transplantation.
    Watson DM; Sherry KM; Weston GA
    Anaesthesia; 1991 Apr; 46(4):285-7. PubMed ID: 2024747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent inotropes for advanced heart failure: inquiring minds want to know.
    Silver MA
    Am Heart J; 1999 Aug; 138(2 Pt 1):191-2. PubMed ID: 10426825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inotropic therapy in heart failure: general aspects and clinical results].
    Manito N; Kaplinsky EJ; Pujol R
    Med Clin (Barc); 2004 Feb; 122(7):269-74. PubMed ID: 15012878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home inotropic therapy in children.
    Berg AM; Snell L; Mahle WT
    J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
    Kelly J; Cheng J; Malloy R; Lupi K
    J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute decompensated heart failure: the shrinking role of inotropic therapy.
    Dec GW
    J Am Coll Cardiol; 2005 Jul; 46(1):65-7. PubMed ID: 15992637
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
    Alkadri J; Hu R; Jeffers MS; Ross J; McIsaac DI; McDonald B
    Can J Anaesth; 2023 Jul; 70(7):1272-1274. PubMed ID: 37160823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.